Author

Mari Hamao

Kyoto University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:CRISPR screen· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

Chikako OkuboiD· 2 shared Kazutoshi TakahashiiD· 2 shared Michiko NakamuraiD· 2 shared Satoshi SuzukiiD· 2 shared Knut WoltjeniD· 1 shared Lu NiiD· 1 shared Qi FangiD· 1 shared Takuya MurakamiiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Chikako OkuboORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

EIF3H Sustains Translational Programs Essential for Proliferation in Human Primed Pluripotency

Satoshi Suzuki, Chikako Okubo, Michiko Nakamura, Mari Hamao, Qi Fang, Knut Woltjen, Kazutoshi Takahashi

This study identifies EIF3H as essential for human primed pluripotency by regulating translation of metallothionein genes, impacting proliferation and differentiation.

bioRxiv · May 20, 2026 · PreprintCell Biology

Comparative benchmarking of CRISPRi and CasRx in standardized pluripotent stem cell platforms reveals context-dependent knockdown performance

Lu Ni, Takuya Murakami, Satoshi Suzuki, Mari Hamao, Michiko Nakamura, Chikako Okubo, Kazutoshi Takahashi

This study compares CRISPRi and CasRx for gene knockdown in human pluripotent stem cells, finding CRISPRi provides faster and stronger repression but slower recovery, while CasRx offers reversible knockdown with isoform resolution but lower efficiency.

bioRxiv · May 14, 2026 · PreprintCell Biology